hcp.obgyn.net Members: Login | Register
OBGYN.net Recommended Medical Sites Medline Drugs

Powered by SearchMedica

 
  • Home
  • News
  • Blogs
  • Calendar
  • Conditions and Procedures
  • Conferences
  • Tutorials
  • Forum
  • Ultrasound
  • Buyer's Guide

OBGYN.net.
 

Correlation of Sperm Penetration Assay Score with Polyspermy Rate in In-vitro Fertilization

By Vincent W Aoki1, 2, 3, C Matthew Peterson4, Kirtly Parker-Jones4, Harry H Hatasaka4, Mark Gibson4, Ivan Huang4 and Douglas T Carrell1, 2, 3, 4
1 Andrology and IVF Laboratories, University of Utah School of Medicine, Salt Lake City, UT, 84108, USA
2 Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, 84132, USA
3 Department of Physiology, University of Utah School of Medicine, Salt Lake City, UT, 84132, USA
4 Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, 84132, USA | October 9, 2011

Published February  9 2005

Short report

Background

The sperm penetration assay (SPA) is used to predict the fertilizing capacity of sperm. Thus, some programs rely on SPA scores to formulate insemination plans in conjunction with in-vitro fertilization (IVF) cycles. The purpose of this study was to evaluate if a relationship exists between SPA scores and polyspermy rates during conventional IVF cycles.

Methods

A total of 1350 consecutive IVF patients using conventional IVF insemination were evaluated in the study. Oocytes were inseminated three hours post-retrieval by the addition of 150,000 to 300,000 progressively motile sperm. Approximately 18 hours after insemination, the oocytes were evaluated for fertilization by the visualization of pronuclei. The presence of three or more pronuclei was indicative of polyspermy. Polyspermy rates, fertilization success, embryo quality, and pregnancy rates were analyzed retrospectively to evaluate their relationship with SPA score, count, motility, number of progressively motile sperm inseminated, oocyte pre-insemination incubation time, patient age, and diagnosis.

Results

A significant positive relationship was observed between SPA score and polyspermy rate (rs = 0.10, p < 0.05). Patients with a normal SPA score had significantly higher polyspermy rates than those with abnormal SPA scores (6.3% ± 1.5% vs. 2.0% ± 0.7%, p < 0.05). Fertilization percentage was significantly lower in the group with severely abnormal SPA scores versus all other SPA groups (57.5% ± 2.1% vs. 70.2% ± 1.3%, p < 0.005). Although embryo quality was not affected, both clinical pregnancy and implantation rates improved slightly as SPA score increased. In addition, there was a decrease in the rate of spontaneous abortion as SPA score increased.

Conclusions

These data indicate SPA score is positively correlated with polyspermy rates and IVF fertilization percentage. Additionally, there is a slight increase in clinical pregnancy rates, and embryo implantation rates with increased SPA. Furthermore, there is a slight decrease in spontaneous abortions rates related to increased SPA.

Findings

The sperm penetration assay (SPA) is used to evaluate the fertilizing capacity of human spermatozoa [1]. Some in-vitro fertilization (IVF) programs rely on the SPA to formulate their insemination plans in conjunction with IVF cycles [1,2]. Couples with normal SPA scores normally undergo conventional IVF insemination in contrast with intracytoplasmic sperm injection (ICSI), which is used for those with a diminished SPA.

Over the past decades success rates have steadily improved for human IVF embryo transfer programs. Recent advances in ovulation induction, micromanipulation, culturing conditions, and media formulations have fostered a technological revolution for IVF leading into the 21'st century (Pool, 2002). However, many common problems still remain.

One common problem associated with conventional IVF insemination is polyspermic fertilization when more than one sperm successfully penetrates and fertilizes the oocyte. These pre-embryos are considered abnormal and typically discarded. Thus, increased rates of polyspermy ultimately result in a reduced number of embryos.

Studies have been conducted that evaluate the factors associated with human IVF polyspermy [3-5]. However, most of the reports are based on data over a decade old. Recent improvements in IVF techniques may alter these relationships. Furthermore, no study has evaluated the relationship between sperm SPA score and incidence of polyspermy in human IVF.

The purpose of this study was to evaluate if a relationship exists between SPA scores and polyspermy rates during IVF cycles utilizing conventional insemination. We also evaluated the relationship between SPA score and fertilization rate, embryo quality, and pregnancy rate.

After Institutional Review Board approval, we conducted a retrospective study of 1350 consecutive IVF patients using conventional IVF insemination. Intracytoplasmic sperm injection (ICSI) patients were excluded from the study. The fertilizing capacity of each patient was assessed with the SPA. The SPA was performed on patients undergoing IVF using techniques previously described [6]. The SPA was performed on patients less than sixty days prior to the IVF cycle. The SPA score reflects the percentage of eggs successfully penetrated by the patient's sperm. SPA patients were stratified into 4 groups according to SPA score (Group 1: severely abnormal SPA (< 10% penetration), n = 182; Group 2: abnormal SPA (10–19% penetration), n = 368; Group 3: normal SPA (20 – 29% penetration), n = 404; Group 4: high-normal SPA (> 30% penetration), n = 396).

During the IVF cycle ovarian stimulation was performed using standard techniques of gonadotrophin-releasing hormone (GnRH) agonist down-regulation combined with controlled ovarian stimulation using a combination of recombinant follicle stimulating hormone (rFSH) and urinary-derived gonadotropin stimulation. Ovarian follicles were aspirated using a trans-vaginal ultrasound-guided needle.

Oocytes were inseminated three-hours post-retrieval by the addition of 150,000 to 300,000 progressively motile sperm. Approximately 18-hours post-insemination, the oocytes were evaluated for fertilization by visualization of pronuclei. The presence of three or more pronuclei was indicative of polyspermy in which case the fertilized oocyte was discarded. Embryos were cultured in HTF medium and transferred 72-hours post-retrieval. Embryo quality was assessed using a previously reported embryo scoring system that took into account the number of cells present and the level of cellular fragmentation [7].

Polyspermy rates, fertilization success, embryo quality, and pregnancy rates were analyzed retrospectively with respect to their relationship with SPA score. The correlation between SPA score and polyspermy was conducted using Spearman's correlation coefficient. Additionally, polyspermy rates, fertilization percentage, and embryo quality for the different SPA groups were analyzed for statistical difference using Kruskal-Wallis analysis. Lastly, pregnancy rates in the different groups were evaluated with a Chi-square analysis.

A significant positive relationship was observed between SPA score and polyspermy rates in 1350 IVF patients undergoing conventional IVF insemination (rs = 0.10, p < 0.05). Patients with normal SPA scores (Group 3) had significantly elevated polyspermy rates over those with severely abnormal SPA scores (6.3 ± 1.5 – 113/1,791 vs. 2.0 ± 0.7 – 20/1,020, p < 0.05, Table 1, please see file "Table1-Aoki et al.doc", Additional file 1). Conventional IVF fertilization rate was significantly lower in patients with severely abnormal SPA (57.5 ± 2.1 – 1,135/1,974) vs. all other patients (70.2 ± 1.3 – 8,519/12,135; p < 0.005, Table 1, please see file "Table1-Aoki et al.doc", Additional file 1).

Embryo quality showed no relationship to the SPA (Table 1, please see file "Table1-Aoki et al.doc" Additional file 1). Clinical pregnancy and implantation rates were increased in Group 4 (50.8% – 202/396 and 27.4% – 343/1255, respectively) versus Group 1 (31.6% – 58/182 and 15.7% – 96/612, respectively, p < 0.05) but no significant relationship between SPA and IVF outcome was observed throughout the entire study population (Table 1, please see file "Table1-Aoki et al.doc" Additional file 1). Similarly, there was a decrease in the rate of spontaneous abortion in Group 4 (14.7% – 30/202) versus Group 1 (31.3% – 18/58), although no significant relationship was observed within the entire population (Table 1, please see file "Table1-Aoki et al.doc" Additional file 1).

No relationships were observed between IVF polyspermy rates and maternal age, maternal diagnosis, amount of progressively motile sperm added, sperm morphology, ovarian stimulation protocol, or post-oocyte retrieval pre-insemination incubation time. Additionally, confounder analysis indicated the SPA groups were similar with respect to paternal age, maternal age and IVF diagnosis. Therefore, no standardization of the data with respect to these variables was required.

This is the first report to correlate SPA score with IVF polyspermy rates. Significantly elevated IVF polyspermy rates were observed in patients with normal SPA scores. Previous reports have established a relationship between IVF polyspermy and oocyte age/maturation, state of the zona pellucida, number of progressively motile sperm used for insemination, oviductal cytokine expression, and in-vitro culture conditions such as pH, temperature, and media supplementation [5].

Unlike other reports, we did not find a relationship between the number of progressively motile sperm used for insemination and IVF polyspermy rates. This discrepancy is most likely due to the narrow range of sperm number we used for insemination (150,000 to 300,000) compared with the studies of van der Ven et al. who used 500,000 to 1.5 *106 sperm [4]. Our results are consistent with Ho et al. who found no relationship between these variables [3]. However, the data still suggest minimizing the number of sperm added for IVF insemination in patients with increased SPA scores.

Poly-pronuclear formation in in-vitro fertilized eggs usually arises from polyspermic fertilization but may also be a product of second polar body retention [8]. Thus, one potential pitfall of associating poly-pronuclear fertilized oocytes with polyspermy is the uncertainty related to second polar body retention. However, a recent report showed only a small percentage of fertilized oocytes with three-pronuclei (2.5%) arise from second polar body retention. The findings of this study validate our study design of categorizing poly-pronuclear fertilized oocytes as polyspermic. Moreover, we would expect the contribution of second polar body retention to be consistent throughout the SPA groups negating any confounding effects.

Consistent with other reports, the SPA was correlated with fertilization percentage [1,6]. Furthermore, clinical pregnancy and implantation rates did show improvement in patients with a high-normal SPA versus those with a severely abnormal SPA. In addition, spontaneous abortion rates were significantly different between these two groups. This data strongly suggests ICSI may be an attractive alternative for patients with severely affected penetration ability.

Done correctly, the SPA provides a reliable assessment of the fertilizing ability of human spermatozoa with very low false negative rates (< 0.03%) and serves a valuable tool for clinicians to treat infertility patients with the appropriate modality [9]. The SPA is particularly useful in light of recent concerns about ICSI and imprinting diseases [10-12]. These concerns have led to the recommendation that IVF clinicians should be careful to employ the technique only when necessary and the SPA provides a prognostic tool to appropriately make that decision. Based on these findings, it may be valuable for individual IVF programs to re-evaluate the clinical utility of SPA testing. The SPA may prove valuable for clinicians to avoid increased amounts of polyspermy and unnecessary wasting of oocytes. Meanwhile, the SPA does not appear to be a reliable indicator of IVF embryo quality or pregnancy rates.


Authors' Contributions

VWA designed the study, carried out statistical evaluation, and was the primary author of the manuscript. CMP, KPJ, HHH, MG, and IH were involved in management of the IVF cases and collection of the clinical data. DTC was responsible for the implementation of the study, administrative requirements including IRB approval, statistical evaluation of the data, and preparation of the manuscript.

 

Join the Conversation

Want to join the conversation? Just sign in or register today to become part of our growing, online community.





Journal of Experimental & Clinical Assisted Reproduction 2005, 2:3
doi:10.1186/1743-1050-2-3

© 2005 Aoki et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References
1. Carrell DT: Semen analysis at the turn of the century: an evaluation of potential uses of new sperm function assays. Arch Androl 2000, 44:65-75. [PubMed Abstract][Publisher Full Text]
2. Zahalsky MP, Zoltan E, Medley N, Nagler HM: Morphology and the sperm penetration assay. Fertil Steril 2003, 79:39-41. [PubMed Abstract][Publisher Full Text]
3. Ho PC, Yeung WS, Chan YF, So WW, Chan ST: Factors affecting the incidence of polyploidy in a human in vitro fertilization program. Int J Fertil Menopausal Stud 1994, 39:14-19. [PubMed Abstract]
4. van der Ven HH, Al-Hasani S, Diedrich K, Hamerich U, Lehmann F, Krebs D: Polyspermy in in vitro fertilization of human oocytes: frequency and possible causes. Ann N Y Acad Sci 1985, 442:88-95. [PubMed Abstract]
5. Wang WH, Day BN, Wu GM: How does polyspermy happen in mammalian oocytes? Microsc Res Tech 2003, 61:335-341. [PubMed Abstract][Publisher Full Text]
6. Carrell DT, Bradshaw WS, Jones KP, Middleton RG, Peterson CM, Urry RL: An evaluation of various treatments to increase sperm penetration capacity for potential use in an in vitro fertilization program. Fertil Steril 1992, 57:134-138. [PubMed Abstract]
7. Carrell DT, Peterson CM, Jones KP, Hatasaka HH, Udoff LC, Cornwell CE, Thorp C, Kuneck P, Erickson L, Campbell B: A simplified coculture system using homologous, attached cumulus tissue results in improved human embryo morphology and pregnancy rates during in vitro fertilization. Journal of Assisted Reproduction and Genetics 1999, 16:344-349. [PubMed Abstract][Publisher Full Text]
8. Porter R, Han T, Tucker MJ, Graham J, Liebermann J, Sills ES: Estimation of second polar body retention rate after conventional insemination and intracytoplasmic sperm injection: in vitro observations from more than 5000 human oocytes. J Assist Reprod Genet 2003, 20:371-376. [PubMed Abstract][Publisher Full Text]
9. Carrell DT, Udoff LT, Hatasaka HH, Jones KP, Peterson CM: Predictability / variability of a modified sperm penetration assay (SPA): review of 1033 patients undergoing zona-free hamster oocyte sperm penetration analyses / IVF. Adv Reprod 1998, 1:45-56
10. Maher ER, Brueton LA, Bowdin SC, Luharia A, Cooper W, Cole TR, Macdonald F, Sampson JR, Barratt CL, Reik W, Hawkins MM: Beckwith-Wiedemann syndrome and assisted reproduction technology (ART). J Med Genet 2003, 40:62-64. [PubMed Abstract][Publisher Full Text]
11. Gosden R, Trasler J, Lucifero D, Faddy M: Rare congenital disorders, imprinted genes, and assisted reproductive technology. Lancet 2003, 361:1975-1977. [PubMed Abstract][Publisher Full Text]
12. DeBaun MR, Niemitz EL, Feinberg AP: Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet 2003, 72:156-160. [PubMed Abstract][Publisher Full Text] [PubMed Central Full Text]

The electronic version of this article is the complete one and can be found online at: http://www.jexpclinassistreprod.com/content/2/1/3

We would like to invite you to submit your next manuscript to Journal of Experimental & Clinical Assisted Reproduction (JECAR).
JECAR is an Open Access, peer-reviewed, online journal that considers manuscripts on all aspects of reproductive endocrinology, infertility, bioethics and the advanced reproductive technologies. The journal serves a relatively new field, focusing on the diagnosis and treatment of complex human reproductive problems - a sub-speciality of obstetrics and gynaecology."


TopicIndex

 

Adhesions
Breast Health and Breast Care
Contraception
Electronic Health Records (EHRs)
Endometriosis
Fetal Monitoring
Fibroids
Gestational Diabetes
Gynecologic Oncology
Hysterectomy
Infertility
In Vitro Fertilization (IVF)
Laparoscopy
Malpractice

  Menopause
Osteoporosis

Polycystic Ovary Syndrome
Postpartum Depression
Pelvic Pain
Premenstrual Syndrome/Premenstrual Dysphoric Disorder (PMS/PMDD)
Pregnancy and Birth
Sex-related Issues
Ultrasound
Urogynecology
Uterine (Endometrial) Polyps
Weight Management
Young Women

 

MedicaForums

App to compute fetal weight percentiles
Medica Forums - 5/23/13
Hello,

Has anyone tried FetalGrowth app (App Store for iPhone/iPad) ? I'm interested in using a simple and handy tool to calculate fetal percentiles, and I came across this app, which seems it does the job (plots growth charts, as well). I haven't seen anything else, besides this app, so I was wondering if there are people who have already tried it.

Thanks !
Atypical endometrial cells
Medica Forums - 5/19/13
Had a case the other day with the above finding on a pap. She was age 36 and had a Mirena in place. How do people feel about the idea of trying to do an EMB with an IUD in place? If not, how do we proceed?
Welcome to the new ObGyn.net Forum!
Medica Forums - 5/12/13
Welcome to the new ObGyn.net Forum!

To all the members of OB-GYN-L… Thank you for coming! I’m thrilled that you’ve decided to check out the new Forum site, and look forward to reading about what’s on your mind.

If you’re new to the ObGyn.net community... welcome aboard! You’ve just joined an outstanding group of physicians and health care professionals who have been sharing information, answering questions, and building professional relationships via the site’s listserv for nearly 20 years.

Feel free to poke around on the site to get a feel for things, or take a look at the Help Topics page for instructions on how to use the different features of the site.

A few quick tips:
For those of you who like getting new Forum messages delivered directly to your inbox, the first thing you’ll want to do is click on the ‘Follow this forum’ button on the main page. You’ll have the option of getting notifications immediately, as a daily digest, a weekly digest, or only when you’re not online (which is to say, if you’re on the site when someone posts a message, you won’t be notified of it). You won’t be able to post on the site just by replying to the email, but the message will contain a link that takes you directly to the message you’d like to reply to.

You can also follow individual conversations without following the whole list by going into the topic and clicking the ‘Follow this topic’ button next to the title.

Also, in ‘My Profile’ you can:
  • Enter your professional information, including specialty, subspecialty, and education (by clicking ‘Edit my profile’)
  • See your activity on the Forum, such as what discussions you have initiated or replied to, content you’ve ‘liked,’ and activity of people you’ve made your friends
In ‘My Settings’ you can:
  • Add or change your photo
  • Edit your birthday, gender, interests, location
  • Create a signature for your posts
  • Change the types of content you get notifications for, or change the way you receive notifications
If you have questions, feel free to respond to this post or send me a direct message by clicking on the envelope icon.

Happy posting!
Retained Placenta (Ronald Ainsworth – February 2013)
Medica Forums - 5/11/13
I helped another physician with removal of a retained placenta last night, we were unsuccessful in removing it vaginally, her cervix was too closed to allow manual removal and we could only get a few pieces out with ring forceps and a large curette, so we did a laparotomy/hysterotomy and were able to preserve the uterus. The placenta turned out not to be an accreta and it was easily removed via that route through a low vertical incision on the uterus. Any thoughts on the appropriate CPT code would be appreciated. The patient came in through the ER five days after home delivery by her husband. She was severely anemic, rcvd 7 units of blood and is still quite ill and in the ICU but improving.

Ronald E. Ainsworth, MD, FACOG
Attendance in L and D
Medica Forums - 4/15/13
Recently, I had the occasion to review a case of a term primigravida with PROM in a private hospital (no housestaff or in house obstetricians). She was seen by an obstetrician soon after arrival, evaluated, and pitocin induction begun.

She did not deliver for around 29 hours after admission, and the delivering obstetrician (a different physician) was physically present during the last 2 hours of labor prior to delivery.

Simply put, while the two involved obstetricians were in communication by phone with the nursing staff throughout labor (separately as their "shifts" did not overlap), no one actually came to the bedside and wrote a note) from admission until around 2 hours before delivery.

Medical staff bylaws call for a daily progress note; this bylaw was easily met.

In reviewing the case, it did not "feel good" that no one came to the bedside.

My questions:

1. Does anyone have or know of any guidelines to mandate such bedside attendance? Of course, we all hope that the involved physicians would not need said guidelines.
2. Does anyone have a suggestion of hospital/nursing protocols? Simply, in this case I would like to have had a charge nurse or bedside nurse simply say, "Hey, no one has been by for a while. What's up?"

Garry
Basic Textbooks for an Ob/Gyn resident
Medica Forums - 4/12/13
Hey, what textbooks would you advise for my son who is beginning residency this summer?

Post here or email privately if better.

Thanks,

Garry
Facelift cost
Medica Forums - 4/8/13
<p>Hello  friends ,

           I want to know how much does a facelift cost on average? Do you know anyone what is facelift cost ? please help me .........
Cosleeping Survey help
Medica Forums - 4/7/13
Hello,

I really need help from OB/GYNs and I'm having a hard time getting it. I find your opinions really valuable. I'm researching recommendations for cosleeping. This is for my dissertation, so your time is truly appreciated! Please complete the full survey. It will help me tremendously.

The study takes about 5 to 10 minutes to complete. Please don't hesitate to contact me at bhamel@pacificu.edu with any questions.

If you are interested in participating, please follow the link provided below:

https://www.surveymonkey.com/s/Cosleeping

Thank you in advance for your time. If possible, please forward this to other OB/GYNs you know.

Sorry if this an innappropriate use of the forum. But it seems like the right place to find the participants I need.
Those Wonderful And Useful EMRs
Medica Forums - 4/7/13
.

Our hospital bought an electronic medical record (EMR) system for the clinics. There is a large hosptial group practice including pediatrics, medicine, FP, OB/GYN, and other specialities and sub-specialities. Furthermore, the hospitalists and the ER doctors are also employed in the same hosptial group practice.

The hospital spent millions of dollars on an EMR. As best I can tell there are only two useful things that the EMR does. One is to automatically calcualte the BMI, which it does very well. THe other is to make records available on any patient to any doctor anywhere in the practice. It does not do this well -- it requires lots of mouse movements and clicks and different documents come up in different formats, making it labor intenisve. But, with enough time, effort, and frustration, one can obtain copies of every document in the sustem, either on a computer screen or on paper.

Swith to the ER now. A paitnet whom I had seen the previous week in consultatio comes into the ER for a non-pregnancy problem. They call me on the telephone in the evening. "No problem", I say. I did a torough evaluation and wrote a detailed note on the patient and her OB and non-OB problems only a few days ago. "Just go to the EMR and you can print out my note with all the details."

Seems, however, that for some reason the EMR is not available in the ER (or on the wards for that matter). When I asked the hosptial administrator about it the next morning, he said that he and the hosptial lawyers were working on the problem.

Apparently the government thinks that the ER doctors and hospitalists have nothing better to do with their time than to print out copies of patients' medical records from the EMR and sell them on the black market. Therefore, we cannot let those nasty doctors have access to the EMR records. Nevermind that the ER doctors are in the same group practice as all the other doctors. Never mind that the patient is willing to sign a release so that the doctor who is taking care of her can see the records of the practice. We have to protect the patient even if it means that vital information is rendered unavailable and that things are made more difficult, complicated, and expensive. It reminds me of the Army in Viet Nam where they would have to "destroy a village in order to save it!" Apparently the EMR makes us destroy a patient in order to save her.

Thank GOD for the EMR. Three million dollars and the only benefit is that we can get a BMI 10 seconds faster.

I think the NEJM got it correct last month when they said in an atricle that the only ones who truly benefit from electronic medical record systems are the people who make and sell them.



Dean Huffman
Decline in Semen Concentration.
Medica Forums - 4/7/13
Decline in Semen Concentration and Morphology in a Sample of 26,609 Men Close to General Population Between 1989 and 2005 in France


http://www.medscape....22498EV&spon=16

EducationalTutorials


Educational Tutorial: Complications of Laparoscopy
February 7, 2012

There are a variety of complications that can occur during laparoscopic surgery. In this tutorial learn some of the complications and tips to avoid them.

Educational Tutorial: Low Molecular Weight Heparin in Recurrent Abortions
January 17, 2012

Review information on low molecular weight heparin in recurrent miscarriages in this educational tutorial.

Laparoscopy in Infertility An Evidence Based View
October 14, 2011

Thromboembolic Disease in Pregnancy and Puerperium
September 14, 2011

What to Know About: Prenatal Care, Labor and Delivery
August 17, 2011

CaseStudies


Fetal Abdomen with Gallbladder Calculi
Dr. Muktachand and Dr. Trupti , September 27, 2011

B mode and 3D Ultrasound images of a fetal abdomen (35wks) revealing gallbladder calculi

Sacrococcygeal Teratoma?
Dr. Jaydeep , September 14, 2011

This case study shows a 26 week gestation with a cystic mass close to the sacrum.

Fetal Cardiac Anomalies
Joshua Abbott Copel, MD OBGYN.net Advisory Board Member , July 19, 2011

CC is a 31 year old primigravida who was referred for ultrasound at a community hospital due to suspected cardiac anomalies noted on a screening sonogram at her doctor's office. Due to concern about a probable cardiac abnormality an amniocentesis was performed at the local hospital.

Single Umbilical Artery Color Doppler
Abana Cerekja , June 15, 2011

Single umbilical artery color doppler, transverse scan of urinary bladder shows single umbilical artery (left), transverse section of umbilical cord showing only two vessels: one vein and one artery (right).

Ductus Venosus Spectral Waveform
Dr. Joe Antony , June 15, 2011

Normal 35 week pregnancy

FromPhysiciansPractice

Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

  • On This Site
  • Most Emailed
  • On This Topic

MostPopular

  • DailyDx: A 12-Week Fetus

    APR 23 2013 OBGYN.NET READ >>

  • Daily Dx: Young Lady with Abdominal Pain

    MAY 1 2013 OBGYN.NET READ >>

  • The Relationship Between Placental Location and Fetal Gender (Ramzi’s Method)

    JUN 14 2011 OBGYN.NET READ >>

  • Daily Dx: Pelvic Pain with Discharge

    MAY 7 2013 OBGYN.NET READ >>

  • Endometrial Polyps

    JUN 21 2011 READ >>

MostPopular

  • Prophylactic Progesterone May Be Harmful in Twin Pregnancies

    MAY 8 2013OBGYN.NET READ >>

  • Early Surgically-Induced Menopause Linked with Cognitive Decline

    MAY 9 2013OBGYN.NET READ >>

  • The Relationship Between Placental Location and Fetal Gender (Ramzi’s Method)

    JUN 14 2011OBGYN.NET READ >>

  • Postsurgical Levonorgestrel IUD Improves Endometriosis Symptoms

    APR 24 2013OBGYN.NET READ >>

  • FDA Approves “Morning Sickness” Medication

    APR 17 2013OBGYN.NET READ >>

MostPopular

  • Daily Dx: Young Lady with Abdominal Pain

    MAY 1 2013 OBGYN.NET READ >>

  • Laparoscopy in Infertility An Evidence Based View

    OCT 14 2011 OBGYN.NET READ >>

  • Infertility Management: Practical Messages

    AUG 8 2011 OBGYN.NET READ >>

  • Hysteroscopic Removal of Calcified Fragments

    APR 25 2013 OBGYN.NET READ >>

  • Female Infertility: Hypoplastic Uterus

    JUN 24 2011 READ >>

 

 

 

SearchMedicaSearchResult

Find peer-reviewed literature and websites for practicing medical professionals

CME on Infertility
Evidence on Infertility
Guidelines on Infertility
Patient Education on Infertility
Clinical Trials on Infertility
Practical Articles on Infertility
Research and Reviews on Infertility
All "Infertility" results

EventCalendar

  • The 5th IVI International Congress: Reproductive Medicine and Beyond by ComtecMed
    04-Apr-13 to 06-Apr-13 Seville , SPAIN (GYN - Contraception & Reproductive Health)
     
  • 2013 AIUM Annual Convention by American Institute of Ultrasound in Medicine
    06-Apr-13 to 10-Apr-13 New York (New York Marriott Marquis Hotel) , NY USA (CME - Medical Education)
     
  • Manejo clínico y terapéutico de la esterilidad. Segundo curso online by Fundacio Dexeus Salud de la Mujer
    09-Apr-13 to 31-May-13 online , SPAIN(gynecology)
     
  • Pediatric Nursing: Care of the Hospitalized Child by Continuing Education Inc.
    10-Apr-13 to 13-Apr-13 Anaheim (Hyatt Regency Orange County) , CA USA (CME - Obstetrics, Gynecology & Women's Health)
     
  • Medicina fetal Curso-Taller. Curso de Nivel I y II de la SESEGO by Fundacio Dexeus Salud de la Mujer
    15-Apr-13 to 17-Apr-13 Barcelona (Auditorio Salud de la Mujer Dexeus) , SPAIN (OB - Maternal Fetal Medicine)
     
  • Female Urology & Urogynecology Symposium (FUUS) by Quadrant HealthCom, Inc
    18-Apr-13 to 20-Apr-13 Las Vegas (ARIA) , NV USA (CME - Obstetrics, Gynecology & Women's Health)
     
  • Female Urology and Urogynecology Symposium (FUUS) 2013 by Quadrant HealthCom, Inc
    18-Apr-13 to 20-Apr-13 Las Vegas (ARIA) , NV USA (CME - Obstetrics, Gynecology & Women's Health)

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy